Leerink partners and Citibank maintained various ratings on 89bio, noting potential benefits from Trump-era tariffs and onshoring.
1 report, 1 independent
Updated Aug 19
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Leerink partners and Citibank maintained various ratings on 89bio, noting potential benefits from Trump-era tariffs and onshoring.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
89bio
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider Monkey89bio, Inc. (ETNB) Reports Second-Quarter Results; Leerink Partners and Citi Maintain ‘Buy’ Ratings With significant hedge fund interest and a share price under $10, 89bio, Inc. (NASDAQ:ETNB) secures